Ogoc, Antonio M.
HRN: 28-51-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/03/2026
02/09/2026
IV
600mg
Q8
Cellulitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines